Form 8-K - Current report:
SEC Accession No. 0001213900-25-055700
Filing Date
2025-06-18
Accepted
2025-06-18 17:10:17
Documents
19
Period of Report
2025-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246131-8k_adial.htm   iXBRL 8-K 51186
2 PLACEMENT AGENCY AGREEMENT, DATED AS OF JUNE 16, 2025, BY AND BETWEEN ADIAL PHAR ea024613101ex1-1_adial.htm EX-1.1 47065
3 FORM OF SERIES D WARRANT ea024613101ex4-1_adial.htm EX-4.1 91050
4 FORM OF SERIES E WARRANT ea024613101ex4-2_adial.htm EX-4.2 90026
5 FORM OF PRE-FUNDED WARRANT ea024613101ex4-3_adial.htm EX-4.3 88126
6 FORM OF SECURITIES PURCHASE AGREEMENT, DATED JUNE 17, 2025 ea024613101ex10-1_adial.htm EX-10.1 213974
7 FORM OF AMENDMENT NO.1 TO SERIES B-1 COMMON STOCK PURCHASE WARRANT AND SERIES C- ea024613101ex10-2_adial.htm EX-10.2 18507
8 PRESS RELEASE DATED JUNE 17, 2025 ea024613101ex99-1_adial.htm EX-99.1 11614
  Complete submission text file 0001213900-25-055700.txt   934112

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE adil-20250616.xsd EX-101.SCH 3005
10 XBRL LABEL FILE adil-20250616_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE adil-20250616_pre.xml EX-101.PRE 22352
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0246131-8k_adial_htm.xml XML 3685
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 251057766
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)